StratDeck

Two stocks in Drug Manufacturers - General

Bristol-Myers Squibb vs Pfizer: profit, growth, debt and price compared

Bristol-Myers Squibb and Pfizer are each stronger on 3 of 7 figures: Bristol-Myers Squibb on profit margin, sales growth and price for its expected profit; Pfizer on debt, dividend and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Bristol-Myers Squibb's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Bristol-Myers Squibb and Pfizer side by side
Bristol-Myers SquibbBMYPfizerPFE
Net marginStronger: 18.5%6.3%
Revenue growth, past yearStronger: +6.93%−0.43%
Debt to equity191.5%Stronger: 71.0%
Forward P/EStronger: 8.9×9.5×
Dividend yield4.23%Stronger: 6.13%
AnalystsBuy · 24Buy · 26
From its 200-day average+1.2%Stronger: +6.1%

Share price over the past year

  • Bristol-Myers Squibb+26.6%
  • Pfizer+10.3%

18 Nov 202518 Nov 2026

Bristol-Myers Squibb or Pfizer: which is stronger?

  • BMY

    Which is more profitable?

    Bristol-Myers Squibb keeps more of each sale as profit: 18.5% against 6.3%.

  • BMY

    Which is growing its sales faster?

    Bristol-Myers Squibb is growing its sales faster: +6.93% over the past year, against −0.43%.

  • PFE

    Which has borrowed less?

    Pfizer has borrowed less: its debt is 71.0% of what its shareholders own, against 191.5% for Bristol-Myers Squibb.

  • BMY

    Which costs less for the profit it is expected to make?

    Bristol-Myers Squibb costs less for the profit it is expected to make: 8.9× its forward earnings, against 9.5×.

  • PFE

    Which pays more in dividends?

    Pfizer pays more back in dividends for what a share costs: 6.13% a year, against 4.23%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • PFE

    Which is in the stronger price trend?

    Pfizer's price is in the stronger trend: 6.1% above its 200-day average, against 1.2% above.

What each company does

BMYBristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Reports results on 4 February 2027

PFEPfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Reports results on 2 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.